Keene David K reported IBO

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001493152-26-050292

Machine-readable

Structured copy

Timestamps

Event (reported)

Oct 7, 2026

Published

Nov 5, 2026

Ingested by INSIDER

Nov 6, 03:18 UTC

Last re-read

Nov 6, 19:01 UTC

Extracted facts

Filer

Keene David K

Role

Director

Transaction

Grant or awardAs filed: “A”

Asset

IMPACT BIOMEDICAL INC.

Ticker

IBO

Shares

4,170

Price per share

$4.54

Value

$18,932

Execution date (reported)

Oct 7, 2026

Owned after transaction

32.1K shares

Days from execution to publication

29

Calculation

What this establishes

Keene David K filed this Form 4 reporting a grant or award of IBO on Oct 7, 2026. It became public on Nov 5, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Director

Keene David Kcik:0002033931

Issuer

IMPACT BIOMEDICAL INC.cik:0001834105

Revision history · 0

No field has changed since this record was first ingested.